1

Pul
monol
ogy

HI
STOLOGY

1.T/Fregardingther espir
atorytract(2012OCT)
a)Upperr espirat
orytracthasci l
ia
b)APUDcel l
sar escatteredinthelowerrespi
rator
ytr
act
c) Br
onchioleshaveagoodsmoot hmusclelayer
d)Macr ophagesar eint heli
ningoft heal
veol
i
e) Vi
sceralpleuracontainslymphat ics

2.HistologyofRespi r
atoryepi
thel
ium( 2011-OCT)
f) Upperr espirat
orytractepi
theli
um hasci l
ia
g)Br onchiolesar emadeofpr edomi nantl
ysmoothmuscles
h)Macr ophagesar eseenonal veolarepit
heli
um
i
) APUDcel l
sar efoundscatter
edamongl owerrespi
rat
oryt
ractepi
thel
ium
j
) viscer alpleurahaslymphat i
cs

3.Regardingrespi r
atorySyst
em ( 2008OCT)
k) Upperrespirator
yt r
acti
sl i
nebyci l
iat
ed-mucosa
l
) Alveolarli
ninghasMacr ophages.
m)Viscéralpleurahasl ymphatics.
n)Smoot hmuscl ecell
sarepr ominentinbronchi
oles
o)Neur oendocr i
necel l
sarefoundi ntheepit
heli
um

PHYSI
OLOGYANDI
NVESTI
GATI
ONOFLUNGDI
SEASES

4.RegardingLungphysiol
ogy( 2007OCT)
p)FEV1/ VChel
pstoassesst heprogressi
onofBA
q)LowPaCO2i ndicatesmil
dast hma
r) FEV1/VC>80%i sseeninpulmonar yfi
brosis
s) Pulmonar
yarter
iol
esincreasespulmonar yvascul
arr
esi
stance
t) Pulmonar
ycapil
lari
esaresur r
oundedbyal veol
i

5.Regardinggast ransport(2010OCT)
u)Oxygenbi ndingtightenstheglobi
nchainsi
ntheHb
v) Bohreffectisduet oincreasedCO2
w)Whent heP50i ncreasestheO2-Hbcurveshi
fttor
ight
x) Deoxygenat edHbhasmor ebuff
eri
ngacti
onthanoxyHb

6.RegardingCO2t ranspor t(2010OCT)

y) Di
ssolvedCO2i smai nlyfrom theproducti
onofCO2
z) Mai
nbuf f
erint heinterstit
ialfl
uidisbicar
bonat
e
aa)I
ncreasedrenalexcr etionofHCO3i nhypovent
il
ati
on
ab)I
ncreasedacidsecr etioninr espi
rator
yalkal
emia
ac)Mai
nmodeoft ranspor ti
sascar baminocompounds

7.WOFwoul dshi
ftt
heoxygen-
Hbdi
ssoci
ati
oncur
vef
rom At
oB(
tor
ight
)(2008OCT)
ad)Chr
onicanaemia
ae)Al
kalosi
s
af)I
ncreasedTempérat
ure
 2

ag)Hypokalaemia
ah)I
ncreased2,3-DPG

8.Pulmonar yci
rcul
ati
on( 2007OCT)
ai
)Itisconti
nuati
onofsyst emiccircul
ati
on
aj)I
tis1/5ofbloodcircul
ation
ak)Al
veolargascontentsdiff
erineveryexpir
ati
on
al
)Alveolargasexchangedi ff
ersinpostur
e
am) Deadspacei snotpar ti
cipat
inginnormalbr
eat
hing

9.Lungvol umes( 2007MARCH)

an)Emphysemacausesi ncreasel ungvolumes
ao)Restri
cti
velungdiseasesr educealll
ungvolumes
ap)Residuallungvol
umei smeasur edbyHelium di
lut
ionalmet
hod
aq)Withincreasi
ngageFRCwi l
lreduce
ar)Vi
talcapacityofahealthyadul tisar
ound70ml /kg

10.Respir
atoryphysiology(2006OCT)
as)Alveolar[O2]=at mospheric[O2]
at)Tidalvolumeinanor malindivi
dual=400ml
au)Deadspacei snoti ncludedinTidalvol
ume
av)Inexpirati
on,f
irstremovedai ri
sdeadspace
aw) Af terqui
etexpi r
ationli
ngvolumeis300ml

11.Tco;(2006OCT)
ax)Markedlyreducedinpulmonaryhaemor
rhage
ay)I
ncreaseinrightt
oleftshunt
s
az)Become½ i npneumonect omy
ba)Reducedinanaemi ai
nCRF
bb)Correl
ateswellwit
hbloodHb

12.T/Fregardi
ngl ungphysiology(2006MARCH)
bc)Airwayresist
ancei smainlydependonsmal lairways
bd)Lungcompl i
anceagainstlungvolumeisasi gmoidcurve
be)Anycondi t
ionincreasi
ngl ungcompli
anceisl i
kelytoi
ncreasefunct
ionalr
esi
dualcapaci
ty
bf)Flowmeasur ement smai nl
ydependonsmal lairways
bg)Flow-vol
umecur vesareusefuli
nmeasuringsmal l
erai
rwaydisease

13.T/Fregardingfeatur
esofhypercapnea(
2006MARCH)
bh)Flappingtremor
bi)Headache
bj)Tetany
bk)Impairedfingernosetest
bl)Extensorplantarresponse

14.Regar
dingspi
rometry(2005OCT)
bm) TLCcanbemeasur ed
bn)VCcanbecheckeddi rectl
y
bo)FEV1isnotdependentont heeff
ort
bp)FEV1/FVCisi
ncreasedinr est
ri
cti
velungdi
sease
bq)70-80%ofFVCisexpiredinFEV1
 3

15.Spi
rometryisusedtomeasur
e,(
2013APR)
br)Functi
onalresi
dualvol
ume
bs)Vit
alcapaci
ty
bt)TLC
bu)Deadspace
bv)Dif
fusi
oncapacity

16.I
ncreasedCOdi f
fusi
onseeni n(
2006OCT)
bw) Lunghaemor rhages
bx)Compl eteresecti
onofonelung
by)Asthma
bz)Lefttorightshunts
ca)Polycythaemia

17.DLCOi ncr easedi n(2010OCT)

cb)Pul monar yt hromboembol i
sm
cc)Pul monar yhemor rhage
cd)Vigor ousi sotonicexerci
se
ce)Livinginal t
itudeof3000met er
s
cf)Intersti
tialfibrosi
s

18.ABGofapat ientpr esenti

ngwithsever
etachypnoea(
2014OCT)
pH7.4
pO28kPa( 11-14)
pCO2 3kPa( 4–5.7)
HCO3-20( 22–24)
Whichofthef oll
owi ngarepossibl
ecauses
cg)Diabet
icket oacidosis
ch)Pulmonaryembol i
sm
ci)Pulmonaryoedema
cj)GBS
ck)Renalfai
lure

19.Art
eri
alhypoxemiaduet
oV/
Qmi
smat
chi
scausedby(
2014OCT)
cl)Pulmonaryoedema
cm) GBS
cn)Asthma
co)Lobarpneumonia
cp)ARDSear l
ystage

20.TypeIrespi
rat
oryfai
lurecauses(
2014OCT)
cq)Ext
rathor
acicobst
r uct
ion
cr)GBS
cs)Pneumonia
ct)ARDS

21.Type1respi
rat
oryf
ail
urei
sseenwi
th(
2013OCT)
cu)COPD
cv)GBS
cw)ARDS
 4

cx)Acutepul
monaryembol
ism
cy)Narcot
icover
dose

22.WOFcancauser espir
ator
yfai
lur
e(2006OCT)
cz)Methylal
cohol
da)OP
db)Kaneru
dc)PCM
dd)Dil
anti
nNa+t oxi
cit
y

23.A65yearol dl adywhi l
emar ket
ingdevelopedsuddenonsetsevereocci pitalheadache.Then
shebecameconf used.Shewasbr oughttothehospi
talduri
ngwhi cht i
meconsci ousness
deter
iorat
edt oGCS5/ 15.Onexami nati
onshehasar api dshal
lowbr eathingwi t
hi nter
mitt
ent
apnoiecperiod*B/ Lplantarswer eupgoi ngwit
hadilatedpupilonther i
ght .BPis
210/110.(Thiswasaver ylongstem)Howwoul dyoudescribeherbr eathingpattern?(BOF
2008OCT)
de)Periodicbreathing
df)CheyneSt okesr espirati
on
dg)Acidoti
cbr eathing
dh)Abdomi nalbr eathi
ng
di)Agonalbr eathing

24.A50yearol dpatientpresentedwit
hcough,
wheezi ng&SOBofonedaydur ati
on.Hewas
admitt
edtot hehospitalandt r
eat
ed.At
ft
ert
hei nit
iali
mprovementhedevel
opedasudden
onsetchestpain,SOBonday2.O/ Ethepat
ientiscyanosed.Whati
sthenextstepi
nthe
management  ?(BOF2008OCT)
dj)O2
dk)Pulmonaryangi ogram
dl)CXR
dm) I ntubation&vent il
ati
on
dn)IVHeparin

25.WOTFar eresult
sofβ2st imulation(2012OCT)
do)I
ncreaseinhear trat
e
dp)I
ncreaseincontr act
il
it
yoft heheart
dq)Peri
pheralvasoconstri
ction
dr)I
nternaluret
hralsphinctercontract
ion
ds)Bl
addermuscl econt r
action

26.Β2agonist(
2010OCT)
dt)Decreasesmucussecr
etion
du)Noef f
ectonmastcel
lfuncti
on
dv)Incr
easescAMP
dw) Longt er
m usecanleadstotol
erancet
osideeff
ects
dx)Hypokalaemi
aisduetoentryofpotassi
um i
ntoskel
etalmuscl
ecel
ls

27.Predominantlyupperl
obelesi
onoft
hel
ungi
nvol
vementi
sseeni
n(2007MARCH)
dy)Histi
ocytosis
dz)Sil
icosi
s
ea)Ankylosi
ngspondylit
is
 5

eb)Tuber
cul
osis
ec)Rheumat
oidart
hri
ti
s

28.Hyperinfl
atedCXR( 2006OCT)
ed)Obtusecar diacangle
ee)Reducecar diacdullness
ef)Antero-posteri
orandt ransversediamet
erequal
eg)Occurswi t
hkyphosi s
eh)Lossofl i
verdullnessinper cussi
on

29.Predominantl
yupperlobelesionsar
eseeni
n(2004OCT)
ei)fi
broti
csarcoidosi
s
ej)sil
icosi
s
ek)extri
nsi
callergi
calveol
it
is
el)Idi
opathicpulmonaryfi
brosis
em) asbest osis

30.Causesforuni
lateralelevat
ionoft
heDi
aphr
agm (
2013OCT)
en)SLE
eo)Lymphangitiscarcinomatosa
ep)Pleur
isy
eq)Dorsalscol
iosis
er)Pulmonaryembol ism

OBSTRUCTI
VEAI
RWAYDI
SEASES

31.Apati
entwi t
hCOPDpr esent
edwit
hPO2-40mmHgandPCO260mmHg(
2014APR)
es)HastypeI Ir
espir
atoryfai
lur
e
et)SpO2islikeytobe75%
eu)Respi
ratoryacidosi
s
ev)NeedhighdoseO2

32.COPD( 2010OCT)
ew)Papil
loedemaisrecognized
ex)Clubbingisanassoci
atedf eat
ure
ey)Respirat
oryaci
dosisindicatetheneedforassist
edvent
il
ati
on
ez)Leukotri
eneantagoni
stsar everyef
fect
iveinthemanagement
fa)Oxygent her
apycanwor senhypoxia

33.Emphysema( 2006MARCH)
fb)α1Ant i
tr
ypsindefi
ciencyisassoci
ated
fc)alveol
iarenotaff
ected
fd)diff
usi
oncapacityisreduced
fe)l
ungcompl ianceisreduced
ff)responsetosalbutamolismorethanbronchi
alast
hma

34.Feat
uresinanattackofmoderat
elysever
eacut
east
hma(
2013OCT)
fg)Hypoxia
fh)Hypercapnea
fi
)Elevatedserum bi
carbonat
e
 6

f
j)El
evatedFRC
f
k)ReducedFEV1

35.Exer
ciseinducedast hma( 2013APR)
fl
)Mor ewithswimmi ngt hanj ogging.
fm)Changei nmastcel losmol ali
tyisaknowncause
fn)Seenimmedi atelyafterexercise
fo)Beta2agoni st
shasnoval ue
fp)Duet olongactingmedi atorr el
ease

36.T/Fregardingexerciseinducedast hma( 2004OCT)

fq)typi
callyoccurssoonaf tert
heexercise
fr)cannotbepr ecipit
atedbyvol untaryhypervent
il
ati
on
fs)thereisarefractoryperiodfoll
owinganat t
ackduri
ngwhichfur
ther
ft)bronchospasm doesnotoccur
fu)inhali
ngwar m humi dif
iedairduringexerci
seresul
tinr
educeddropi
nFEV1

37.T/Fregardingexerciseinducedast hma( 2004OCT)

fv)typi
callyoccurssoonaf tert
heexercise
fw)cannotbepr ecipit
atedbyvol untaryhypervent
il
ati
on
fx)thereisarefractoryperiodfoll
owinganat t
ackduri
ngwhichfur
ther
fy)bronchospasm doesnotoccur
fz)inhali
ngwar m humi dif
iedairduringexerci
seresul
tinr
educeddropi
nFEV1

38.T/Fregardingbronchi alast
hma( 2012OCT)
ga)PEFRchar t
sar egoodt odetectoccupati
onalexposur
e
gb)Exerci
set estsareusedi nchildren
gc)CXRi snothel pfulinthediagnosisofast
hma
gd)Metachol i
npr ovocationt
estusedwhenFEV1<1. 5l
ge)Reversibil
it
yofai rwayobst r
uctionwit
hster
oidssuggest
sanal
ter
nat
ivedi
agnosi
s

39.Fol
lowingarei ndi
cati
ngli
fet
hreat
eni
ngasthma(
2006OCT)
gf)Peakflowr educti
onto60-75%ofexpect
ed
gg)Bradycardia
gh)Cyanosis
gi)Hypotension
gj)Sil
entchest

40.Acutetr
eatmentofexacer bat
ionofbr
onchi
alast
hma( 2014APR)
gk)Repeatedf requentadmini
str
ati
onofbet
aagonist
gl)Leukotreintantagoni
sgt
gm) I VHydr ocorti
sone
gn)IVMg
go)Mucolyticsl i
keNAC

41.Bronchiectasisisassociatedwi t
h(2007MARCH)
gp)Asbest osis
gq)Naildyst r
ophy
gr)Rheumat oi
dar t
hrit
is
gs)Infl
ammat oryboweldi sease
gt)All
ergicpul monaryasper gil
losi
s
 7

42.Leucotr
ieneantagonists(2007OCT)
gu)Bestgivenbyi nhalati
on
gv)Giveadditi
veef f
ectswithst
eroi
dinhal
ati
on
gw) Act swithin48hr s
gx)Preventsexerciseinducedast
hma
gy)Reducesallergicrhini
ti
s

43.Ant
i-choli
nergi
csi nCOPD(2007MARCH)
gz)Shouldnotcombi nedwithBetaagonist
s
ha)Hasshor thalfl
if
ethanbetaagonist
s
hb)Onlyinhalat
ionformisavail
able
hc)Actsonmuscar i
nicr
eceptorsi
nthelungs
hd)Atropi
nelikesideeff
ect
sar ecommon

44.O2therpayofapat ientwi t
hCOPD( 2005OCT)
he)I
ndi catedifPO2<55mmHg
hf)Willimprovet hesur vivalrate
hg)Reducest hepul monar yhypertension
hh)Reducest her ightvent r
icularfai
lur
e
hi)Neur opsychiatri
cf unctionswilli
mpr ovewi
th6h/
day

45.β2agoni
stsinast hmamanagement( 2013OCT)
hj)Reducesbr onchi
almucussecret
ion
hk)Noeffectonmastcelldegranul
ati
on
hl)Withrepeatedusetol
erancecandevelop
hm) Act i
oni sthr
oughcAMP
hn)Hasnoef fectonTcellf
uncti
on

46.Si
deef f
ect sofipr
atr
opi
um bromide(2013APR)
ho)Diarrhea
hp)Urinaryretenti
on
hq)Sweat ing
hr)Paradoxi calbr
onchi
alconst
ri
cti
on
hs)Bradycar dia

I
NFECTI
ONSOFTHERESPI
RATORYTRACT

47.16.I
ncreasedr iskoftuber
culosi
sisseenwi
th(
2013OCT)
ht)Useofi nhaledbet a2agonist
s
hu)Useofi nfl
ixi
mab
hv)Chronicalcohol i
sm
hw) HI Vpat ientwithanormalCD4count
hx)Si
li
cosis
hy)Malnutrit
ion

48.Sideef
fectsofanti
-tubercul
osistr
eatment( 2012OCT)
hz)Commonl yoccursi n1st2mont hsoftreatment
ia)Jaundiceisanindicati
ontostopt r
eatment
ib)Commoni nyoungpeopl ethanelderl
y
ic)Whenr e-st
art
ingshoul dstar
twithonedr ugatati
me
 8

i
d)Ri
fampi
cini
nducedt
oxi
cit
yispr
event
edbygi
vingpyr
idoxi
ne

49.RegardingTBPer icar
dit
is(2011-OCT)
ie)90%AFBposi ti
veinper i
car
diocent
esi
sfl
uid
if)IfADA>40, i
tsusefulfordi
agnosis
ig)Pericardi
alconstri
cti
onwi t
hef f
usi
onispat
hognomi
cforTB
ih)Major i
tycausedbydi r
ectspreadofpul
monaryTB
ii
) Steroidsimproveprognosis

50.Regardingtubercul
intest(2007OCT)
ij) Negati
vetestexcludesTB
ik)2mm i ndurat
ionindicat
esposit
ive
il
) Shoul dnotbedonei nHI Vposi
ti
veindi
vidual
s
im)Notusef uli
nBCGvacci natedpeople
in)Ifpositi
vewithcontactHxbutwi t
houtf
eaturesofor
gani
nvol
vementI
NAHpr
ophyl
axi
sis
gi
ven

51.Pul
monar yTB( 2006MARCH)
io)Mostnewcasesf oundi nSriLanka<30yr sold
ip)Apicalcavit
ati
onisdi agnosti
c
iq)Zei
hl-Neelsonstaintestcandi ff
erent
iateat
ypicalmycobact
ri
ali
nfect
ion
ir)Rif
ampi ci
nisexcludedf rom tr
ialoftr
eatment
is)Negativetuber
culintestexcludesactiveinf
ecti
on

52.33.Hi
stopathologyoftuber
cul
ousgr
anul
oma(
2013OCT)
it)Neutr
ophilinfi
lt
rat
ion
iu)Lymphocytosis
iv)Peri
pheralcaseati
on
iw)Epi
thel
oidcel l
s
ix)Langerhangiantcell
s

53.Drugsandsi deeffectsofTB ( 2013APR)

iy)Ethambut ol-fi
rstSEisl ossofvisualacui
ty
iz)Streptomycin-vest i
bulartoxi
cit
y
ja)Whenhyper sensit
ivereactionoccursalldr
ugsarest
art
edatsamet
ime
jb)Peripheralneuropathyi smor einslowacetyl
ator
s
jc)Ethambut olcauseshi staminereacti
on

54.Nosocomialpneumonia(2005OCT)
jd)Pseudomonascausesi nf
ecti
onsinICU
je)Staph.Aur
eusi sani
mpor t
antpathogen
jf)Mainsourceforthei
nfect
ionisupperrespi
rat
oryt
ractcol
ony
jg)Drugofchoiceiscef
uroxi
me&macr oli
de
jh)Enter
obacteri
aisacommonpat hogen

55.Mycoplasmapneumoni a( 2005OCT)
ji
) Associateswitherythemanodosum
jj) Of
tenpresentswithpr oduct
ivecough
jk)Canbet reatedwithcef ur
oxi
me&er ythr
omycinef
fect
ivel
y
jl
) Cancauset ransversemyel i
ti
s
jm)War m anti
bodiescausesi nt
ravascularhaemol
ysi
s
 9

56.T/FregardingLegi onel
lapneumonia(2012OCT)
jn)Al obarinvolvementisseeni nCXR
jo)IncreaseCKl evel
s
jp)Hyper -natr
aemi a
jq)Coombsposi ti
vehaemolyt
icanaemia
jr)Transami nasel evel
sareelevat
ed

57.Legi
onell
apneumoni a(2006MARCH)
js)Commoni next remesofage
jt)Causedbyanor ganism f
oundi nenvi
ronment
ju)Sputum gram stainisusef
ulindiagnosi
s
jv)Ri
fampiciniseffecti
veintreat
ment
jw)Chroni
clungdi seasepredisposestothecondi
ti
on

58.Psi
tt
acosis(2010OCT)
jx)CausedbyChl amydi apneumoniae
jy)Diagnosedbyser ology
jz)Treatedwitherythromycin
ka)Transmitt
edviar espir
ator
yrout
e
kb)I
fsplenectomyi sthereconsi
deral
ter
nat
ivedi
agnosi
s

59.Psi
tt
acosi
s(2007MARCH)
kc)Causedbychl amydiapneumoni ae
kd)Organism canbeisolatedint
hesput um
ke)Commonl ycauselowerl obepneumonia
kf)Canbecompl i
cat
edwi t
hmyocar di
ti
s
kg)Eryt
hromycinisthedr ugofchoi
ce

60.Hant
avi ruspul monarysyndromeischar
act
eri
zedby(
2007OCT)
kh)Mucocut aneoushaemor r
hages
ki)Di
ffusepul monaryoedema
kj)Deteri
orationofrenalfuncti
ons
kk)Prodromalf everf
or3-5days
kl)Mimicsl eptospi
rosi
sinfecti
on

61.Regardingaller
gicbronchopulmonar yaspergi
ll
osis(
2014OCT)
km) canbecausedbycandi daalbicans
b)Upoerl obetuberculouscavit
yisseen
c) Distalbronchiect
asisisseen
d)i gElevelsaredisproport
ionatel
yhigherthanbloodeosonophi
ll
s

62.Br
onchopulmonar yasper gi
ll
osis(
2010OCT)
a)I nf
ecti
oncommoni nlowerlobethanupperl
obe
b)Causescavi tati
on
c) Leadstofatalpulmonar yhyper
tensi
on
d)Pr oduceslungcar ci
noma
e) Dist
albronchiectasi
siscommonert hanproxi
mal

63.Br
onchopul
monar
yAsper
gil
losi
s(2008OCT)
a)Cavit
yformi
ng
 10

b)DistalBronchiect
asi
sisafeat
ure
c) Li
fethreat
eningpulmonar
yhypert
ensi
oni
sacompl
icat
ion
d)Car ci
nogenictolung
e) l
obes

64.Lungabscess( 2010OCT)
a)Pr edominant l
ycausedbyGr am negati
veor
gani
sms
b)Commonl yduet ohematogenousspread
c) Inapicalsegmentoft heupperloberai
sest
hesuspi
cionofcavi
tat
ingmal
ignancy
d)Thi nwal lsuggesttuber
cul
osis

65.Lungabscess(2013APR)
a)Pr edominantlycausedbyanaerobes
b)Mostcommonl yduetoheamatogenousspread
c) Apicalsegmentraisethesuspi
cionofmal
ignancy
d)Thi nwallsuggestTB
e) Tri
cuspidvalveendocardi
ti
sisacause.

66.38.Pneumocyst i
scariniipneumoni a(2013OCT)
a)Seeni nlungsofhealthyadul t
s
b)Of tenpresentswithpr oducti
vecough
c) Prophylacti
ctreat
menti swithcotr
imaxazol
efor1yeari
nHI
Vpat
ient
s
d)Coi nfect
ionofCMVi nt helungisseen
e) Diagnosedbygr am st ain

67.Pul
monar yinvol
vementseeni n(
2007OCT)
a)Schi stosomaj aponicum
b)Necat oramer i
canus
c) Str
ongyl oidesstercoral
is
d)Ascar islumbr i
coides
e) Ancylostomabr azill
ienze

I
NTERSTI
TIALLUNGDI
SEASES

68.Hi
stol
ogicalf
eatur
esofidiopathi
cpul
monaryfi
brosi
s(2014APR)
a)Thickeningofalveol
arwall
b)Increasednumberoft ypeIpneumocyt
es
c) I
ncreasednumberofmacr ophagesinal
veol
i
d)Increasedfi
brogenesi
s

69.Regardi
ngIntersti
tiall
ungfibr
osis(2013APR)
a)Pr imarypathologyisgranulomaformati
oninthel
owerl
obes
b)St oppi
ngsmoki ngdoesn’tret
ardthepr
ogressi
onofl
anger
hancel
lhi
sti
ocyt
osi
s
c) ARDSi sacause
d)Honey- combi ngseeni nHRCT
e) Usualint
erstit
ialfi
brosi
sisthecommonestcause.

70.Dr
ugswhi chcauseeosi
nophi
li
cpneumoni
a(2013APR)
a)Ni t
rofurant
oin
b)Peni ci
ll
in
c) Aspiri
n
 11

d)Amiadar
one
e) Ami
tr
ypt
il
li
ne

71.WOTFcausespul monar yintersti

ti
alshadowswi
theosi
nophi
li
a(2012OCT)
a)Sul phonami detreatment
b)Al l
ergicbroncho- pulmonar yaspergi
ll
osi
s
c) Loffl
er’
ssyndr ome
d)Langer hancel lhist
iyocytosis
e) Tropicalpul
monar yeosinophili
a

72.T/
Fr egardi
ngEosinophi
li
cpneumoni a(2004OCT)
a)associ at
edwithperi
pheralbloodeosi
nophil
ia
b)knownt ocausebybronchopul monarycandi
dai
nfect
ion
c) f
leeti
ngshadowsseeni nchestXr ay
d)canbecausedbysul phasalazi
ne

73.Sarcoi
dosis( 2013APR)
a)Pol yart
hrit
isiscommonl yassociatedwithhi
larl
ymphadenopat
hy
b)Er ythemanodosum i sseeninforearm
c) Lupusper nioisseeninchroni
cdi sease
d)Associ atedwithHLAB12
e) Bonycyst sareseeninchronicform

74.Hypercalcemiainsarcoidosis(2010OCT)
a)Doesnotcausehypopar at
hyroidism
b)Livermacr ophagespl aysamai nr ol
e
c) Duet oincreased1,25-dihydroxycholecal
cif
erol
d)St eroi
dt r
eatmenti seffecti
ve

75.WOTFar esteroi
dr esponsi velungdiseases(
2012OCT)
a)Cr yptogeni
cor ganizi
ngpneumoni a
b)Rheumat oi
dinterstit
iallungdisease
c) Sarcoidosi
s
d)Idiopathicpulmonar yf i
brosis
e) Non-specifi
cintersti
tialpneumoni a

76.Di
ff
usealveolarhemor rhageisseenin(2010OCT)
a)Wegener sgr anul
omat osi
s
b)Nitrof
urontointherapy
c) Goodpasturessyndrome
d)Disseminatedi nt
ravascularcoagul
ati
on
e) Mit
ralst
enosi s

77.Di
ff
uselunghaemor r
hageseeni
n(2008OCT)
a)MS
b)DIC
c) Goodpasture’
sSyndrome
d)Wegner sgranulomatosi
s
e) Ni
trof
urantointher
apy

78.Regar
dingsi
li
cosi
s(2008OCT)
 12

a)Eggshel lcal
cifi
cati
onisdi agnosti
c.
b)Acut el
ycanpr ésentwithpul monaryoedema
c) Pulmonar yfj
brosisisaf eature.
d)Di seaser emi
taf t
erstoppageofexposur e
e) I
ncr easesthesuscept i
bili
tytopulmonaryTB

79.Di
ffuselungshadowsseeni n(2007OCT)
a)Sar coidosis
b)Mcl eod’ssyndrome
c) Pneumoconi osis
d)Ami odar one
e) Smallcel lCAofthebr
onchus

80.Goodpastuer’ssyndr ome( 2007OCT)

a)Sol ubleimmunecompl exesareseen
b)Typi call
ypr esentswithhaemopt ysis&dyspnoea
c) Treatedwi t
hpl asmapher esi
s&cyt otoxi
cdrugs
d)Neur ologicalfeatureareacommonmodeofpr esent
ati
on
e) Leadst ohighlyselecti
vepr ot
einuri
a

81.Cal
cifi
cati
onofthelungscausedby(
2005OCT)
a)Legi onel
la
b)Var i
cella
c) Spir
ochaetes
d)Hi stopl
asmosis
e) Mycoplasma

MALI
GNANTLUNGDI
SEASE

82.18.Lungcarcinomacanbecompli
cat
edwi
th,
(2013OCT)
a)Hyponat raemia
b)Gener al
izedhyperpi
gment
ati
on
c) SVCobst ruct
ion
d)Hor ner’
ssyndr ome
e) Pulmonaryoedema

83.Br
onchi alcarcinoma( 2008OCT)
a)Squamouscel lcar
cinomadevelopsinthehi l
um
b)Adenocar cinomadevel opsintheperi
pheries
c) Coalwor kerspneumoconi osisisapredisposingcondi
ti
on
d)Mal ignantcel l
sar efoundinsputum
e) Paraneopl asti
csyndr omeisseeninsmal lcel
lcarci
noma

84.RegardingCAlung(2007OCT)
a)90%ofpt swithsquamouscel lCAhasdi st
antmet
satt
het
imeofpr
esent
ati
on
b)Al veolarcel
lCAismult
icentr
icinorigi
n
c) Smal lcel
lCAhasthehighesttumorcelldoubli
ngt
ime
d)Squamouscel lCAcommonl yoccur sproxi
mall
y
e) Canhavenor malCXRatpr esentat
ion

85.Hyper
trophi
cpul
monar
yost
eoar
thr
opat
hy(
2005OCT)
 13

a)Seeni nbronchialadenoma
b)Causesef f
usionoft hejoint
c) Causesperiost
ealr eaction
d)Cont r
aindicati
onf orsur ger
yinbr
onchi
alCA
e) Seenincysticf
ibrosi s

86.WOFareT/Fregardi
ngBr onchialCA( 2004OCT)
a)HPOAi srever
sedafterexcisionofthetumor
b)hypocl
oraemicalkal
osisi scausedbysmal lcel
lCA
c) LEMSi
snotaf f
ectedbyt hesurgicalexci
sionofthetumor

PLEURALEFFUSI
ON

87.Eosinophili
cpleuralef
fusi
oni
scommonl
yseenwi
th(
2013OCT)
a)Chur gstrausssyndrome
b)Pneumot horax
c) Infarct
ion
d)TB
e) Dr essl
er’ssyndrome

88.Tr
ansudativeef fusi
onsar eseeni
nWOTFdi
seases(
2012OCT)
a)Const ri
ctiveper i
carditi
s
b)Yel l
ownai lsyndrome
c) Dressl
ers’ syndrome
d)Hypot hyroi di
sm
e) Connectivet i
ssuedi seases

89.Mali
gnantpleuralef
fusion(2005OCT)
a)Isduet oobst r
ucti
onoft helymphati
cs
b)IfpHi slessthe7.2pr ognosisispoor
c) Amylaselevelwil
lbei ncreased
d)Lymphocyt osisispredomi nant
e) Cytol
ogyofthef l
uidisbet t
erthanbi
opsy

90.Pl
euralfl
uidgl
ucoseconcent
rat
ionof<40mgseeni
n(2013OCT)
a)CRF
b)RA
c) Malignancy
d)Empyema
e) TB

OSA

91.Obst
ructivesleepapnoea( 2014APR)
a)Losswal lchestmovement sduri
ngapnoicat
tack
b)Upperai rwayobst ructi
onistr
ansi
ent
c) Suppli
ment oryO2shoul dberouti
nel
yprescr
ibeddur
ingCPAPmaskbr
eat
hing
d)Br adycardiaisseen
e) Al
coholi sapr eci
pitant

92.T/
Fregar
dingobst
ruct
ivesl
eepapnoea(
2012OCT)
 14

a)Met hylpheni
datei
susedfortr
eatment
b)Cor- pulomonal
eisaknowncompl icat
ion
c) CPAPr educesdayti
mesomnol ence
d)Occur smor ewit
habdominalt
hanneckobesi ty
e) Di
agnosedi fsi
mult
aneouscessationofnasalai
rpassage,
abdomi
nalmovement
sandchest
movement soccuri
npolysomnography

93.Fol
lowi
ngar eseeninapnoei
cspel lofobst
ruct
ivesl
eepapnoea(
2007MARCH)
a)Increasedsystol
icBP
b)Increasedpulmonaryart
erypressure
c) I
ncreasedheartr
ate
d)Decr easePaO2lessthan59mmHg
e) I
ncreasedinci
denceofcardi
acar r
hythmias

94.Sl
eepapnoeasyndr ome( 2006OCT)
a)Loudsnor ingatnight
b)Causesi ncreasebloodpressure
c) Associat
edwi t
hdayt i
medr owsyness
d)Mor ecommoni nmal es
e) I
sar ecognizedri
skfactorI
HD

MI
SCELLANEOUS

95.Regardingpulmonar yembol i
sm ( 2014OCT)
a)VQscani snotaspeci fi
cinvestigati
ontodetectpulmonaryembolism asi
tisaf
fect
edby
otherlungpathologies
b)I fvenousDoppl erisnormal ,pulmonaryembolism canbeexcluded
c) causest ypeIrespir
atoryfail
ure
d)I ftr
oponineIisposi t
ive,pulmonar yemboli
sm canbeexcluded
e) Ifpresentswit
hcar diogenicshock, Str
ept
okinaseiscontr
aindi
cated

96.Tr
ueorf alser egardi
ngacutemount ainsickness(
2014OCT)
a)Causessever eheadache
b)Respi ratoryacidosisisseen
c) Cheynest okebr eathi
ngisr ecognized
d)canbepr eventedbeAcet ozolamide
e) st
artsatahei ghtof1000m

97.Recurr
entepisodesofhaemoptysisat5yeari
nter
val
,fol
lowi
ngcanbepossi
ble(
2013OCT)
a)Pneumoconi osi
s
b)Br onchiectasis
c) Bronchialadenoma
d)Sar coi
dosis
e) Idi
opathicpul monar
yhaemosider
osis

98.t
/Fregardingthepat hogenesisofpulmonaryhyper
tensi
on(
2012OCT)
a)Ther eisadef i
ciencyinNOpr oducti
on
b)Ther eisanendot heli
alcelldysfunct
ion
c) Vascularscarr
ingoccur s
d)Ther eissmoot hmuscl ecellproli
fer
ati
on
e) Endotheli
nlevelsareincreased